DE60222160D1 - Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung - Google Patents
Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzungInfo
- Publication number
- DE60222160D1 DE60222160D1 DE60222160T DE60222160T DE60222160D1 DE 60222160 D1 DE60222160 D1 DE 60222160D1 DE 60222160 T DE60222160 T DE 60222160T DE 60222160 T DE60222160 T DE 60222160T DE 60222160 D1 DE60222160 D1 DE 60222160D1
- Authority
- DE
- Germany
- Prior art keywords
- compositions
- release
- properties
- controlled release
- immediate release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32840501P | 2001-10-12 | 2001-10-12 | |
US328405P | 2001-10-12 | ||
PCT/US2002/032314 WO2003030872A2 (en) | 2001-10-12 | 2002-10-11 | Compositions having a combination of particles for immediate release and for controlled release |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60222160D1 true DE60222160D1 (de) | 2007-10-11 |
DE60222160T2 DE60222160T2 (de) | 2008-06-12 |
Family
ID=23280838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60222160T Expired - Lifetime DE60222160T2 (de) | 2001-10-12 | 2002-10-11 | Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung |
Country Status (12)
Country | Link |
---|---|
US (1) | US6908626B2 (de) |
EP (1) | EP1443912B1 (de) |
JP (5) | JP2005508939A (de) |
AT (1) | ATE371442T1 (de) |
AU (1) | AU2002334939A1 (de) |
CA (1) | CA2463495C (de) |
CY (1) | CY1107810T1 (de) |
DE (1) | DE60222160T2 (de) |
DK (1) | DK1443912T3 (de) |
ES (1) | ES2292848T3 (de) |
PT (1) | PT1443912E (de) |
WO (1) | WO2003030872A2 (de) |
Families Citing this family (147)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080102121A1 (en) * | 1998-11-02 | 2008-05-01 | Elan Pharma International Limited | Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone |
US8551526B2 (en) * | 2000-11-03 | 2013-10-08 | Board Of Regents, The University Of Texas System | Preparation of drug particles using evaporation precipitation into aqueous solutions |
US20080026068A1 (en) * | 2001-08-16 | 2008-01-31 | Baxter Healthcare S.A. | Pulmonary delivery of spherical insulin microparticles |
ATE464880T1 (de) | 2002-02-04 | 2010-05-15 | Elan Pharma Int Ltd | Arzneistoffnanopartikel mit lysozym- oberflächenstabilisator |
US7803402B2 (en) * | 2002-07-06 | 2010-09-28 | Sanjeev Khandelwal | Pharmaceutical preparations |
US20040048931A1 (en) * | 2002-07-12 | 2004-03-11 | Craig Heacock | Modafinil pharmaceutical compositions |
DE10253623B4 (de) * | 2002-11-15 | 2006-03-09 | Justus-Liebig-Universität Giessen | Bioabbaubare kolloidale Partikel, insbesondere für pulmonale Applikationen |
IL153098A0 (en) * | 2002-11-26 | 2003-06-24 | Chemagis Ltd | Pharmaceutical compositions containing modafinil |
US7638138B2 (en) | 2003-02-21 | 2009-12-29 | Translational Research, Ltd. | Compositions for nasal administration of pharmaceuticals |
US20100297252A1 (en) | 2003-03-03 | 2010-11-25 | Elan Pharma International Ltd. | Nanoparticulate meloxicam formulations |
US8512727B2 (en) * | 2003-03-03 | 2013-08-20 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
CN1758930B (zh) | 2003-03-27 | 2010-06-09 | 株式会社新日本科学 | 鼻腔用粉末药剂喷药装置 |
BE1015641A4 (fr) * | 2003-05-26 | 2005-07-05 | Mariani Jean Paul | Micronisation 70. |
US7198653B2 (en) * | 2003-07-31 | 2007-04-03 | Delavau Llc | Calcium carbonate granulation |
US20050058702A1 (en) * | 2003-09-17 | 2005-03-17 | Ben-Sasson Shmuel A. | Compositions capable of facilitating penetration across a biological barrier |
EP1692444A2 (de) * | 2003-10-24 | 2006-08-23 | J. Rettenmaier & Söhne GmbH + Co. KG | Verfahren zum gemeinsamen versprühen von trocknungsmitteln mit trockenem silizifiziertem mcc |
EA011712B1 (ru) * | 2004-03-29 | 2009-04-28 | Ле Лаборатуар Сервье | Способ производства твёрдой фармацевтической композиции |
PL1732605T3 (pl) * | 2004-03-29 | 2019-09-30 | Wyeth Llc | Multiwitaminowe i mineralne suplementy odżywcze |
RU2006138054A (ru) * | 2004-03-30 | 2008-05-10 | Смиткайн Бичам Корпорейшн (Us) | Высушенные распылением фармацевтические композиции |
WO2005108924A1 (en) * | 2004-04-29 | 2005-11-17 | Jadi, Inc. | Artificial horizon device and method |
US8728525B2 (en) * | 2004-05-12 | 2014-05-20 | Baxter International Inc. | Protein microspheres retaining pharmacokinetic and pharmacodynamic properties |
SI21800A (sl) * | 2004-05-14 | 2005-12-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Nov postopek sinteze perindoprila |
US20060165769A1 (en) * | 2004-09-30 | 2006-07-27 | Hyatt John A | Pharmaceutical formulations containing vitamin E TPGS molecules that solubilize lipophilic drugs without significant efflux inhibition, and use of such formulations |
US8246976B2 (en) * | 2004-10-08 | 2012-08-21 | Noven Pharmaceuticals, Inc. | Transdermal delivery of drugs based on crystal size |
CN101106972A (zh) * | 2004-11-16 | 2008-01-16 | 伊兰制药国际有限公司 | 注射用纳米微粒奥氮平制剂 |
UA89513C2 (uk) * | 2004-12-03 | 2010-02-10 | Элан Фарма Интернешнл Лтд. | Стабільна композиція з наночастинок ралоксифену гідрохлориду |
KR20070116581A (ko) * | 2004-12-15 | 2007-12-10 | 엘란 파마 인터내셔널 리미티드 | 나노입자형 타크롤리무스 제제 |
ES2900801T3 (es) | 2004-12-22 | 2022-03-18 | Nitto Denko Corp | Portador de fármacos y kit de portador de fármacos para inhibir la fibrosis |
US20120269886A1 (en) | 2004-12-22 | 2012-10-25 | Nitto Denko Corporation | Therapeutic agent for pulmonary fibrosis |
US20060159767A1 (en) * | 2004-12-22 | 2006-07-20 | Elan Pharma International Limited | Nanoparticulate bicalutamide formulations |
AU2012201630B8 (en) * | 2004-12-31 | 2014-03-06 | Iceutica Pty Ltd | NanoParticle Composition(s) and Method for Synthesis Thereof |
CN101132770A (zh) * | 2005-01-06 | 2008-02-27 | 伊兰制药国际有限公司 | 纳米微粒坎地沙坦制剂 |
EP2353590A1 (de) * | 2005-02-15 | 2011-08-10 | Elan Pharma International Limited | Aerosol und injizierbare Formulierung mit nanopartikulärem Benzodiazepin |
WO2006096462A1 (en) * | 2005-03-03 | 2006-09-14 | Elan Pharma International Limited | Nanoparticulate compositions of heterocyclic amide derivatives |
WO2006099121A2 (en) * | 2005-03-10 | 2006-09-21 | Elan Pharma International Limited | Formulations of a nanoparticulate finasteride, dutasteride and tamsulosin hydrochloride, and mixtures thereof |
EP1861072A2 (de) * | 2005-03-14 | 2007-12-05 | Massachusetts Institute Of Technology | Nanozellen zur diagnose und behandlung von krankheiten und störungen |
JP2008533174A (ja) * | 2005-03-16 | 2008-08-21 | エラン ファーマ インターナショナル リミテッド | ナノ粒子ロイコトリエン受容体拮抗薬/副腎皮質ステロイド製剤 |
EA200701997A1 (ru) * | 2005-03-17 | 2008-02-28 | Элан Фарма Интернэшнл Лтд. | Композиция из наночастиц бисфосфоната |
JP2008534509A (ja) * | 2005-03-23 | 2008-08-28 | エラン ファーマ インターナショナル リミテッド | ナノ粒子副腎皮質ステロイドおよび抗ヒスタミン薬の製剤 |
BRPI0607537A2 (pt) * | 2005-04-12 | 2009-09-15 | Elan Pharma Int Ltd | formulações de derivado de quinazolina nanoparticulado |
WO2006110809A2 (en) * | 2005-04-12 | 2006-10-19 | Elan Pharma International, Limited | Nanoparticulate lipase inhibitor formulations |
MX2007013356A (es) * | 2005-04-27 | 2008-03-26 | Baxter Int | Microparticulas modificadas en la superficie y metodos de formacion y uso de las mismas. |
US20100003373A1 (en) * | 2005-04-28 | 2010-01-07 | Meiji Seika Kaisha, Ltd. | Rapidly soluble granules and method for producing the same |
WO2006119280A2 (en) * | 2005-05-03 | 2006-11-09 | Handylab, Inc. | Lyophilized pellets |
CA2601067A1 (en) | 2005-05-04 | 2006-11-09 | Medigene Ag | Method of administering a cationic liposomal preparation comprising paclitaxel |
WO2006132752A1 (en) * | 2005-05-10 | 2006-12-14 | Elan Pharma International Limited | Nanoparticulate and controlled release compositions comprising vitamin k2 |
JP2008540546A (ja) * | 2005-05-10 | 2008-11-20 | エラン ファーマ インターナショナル リミテッド | ナノ粒子クロピドグレル製剤 |
US20100028439A1 (en) * | 2005-05-23 | 2010-02-04 | Elan Pharma International Limited | Nanoparticulate stabilized anti-hypertensive compositions |
EA015102B1 (ru) * | 2005-06-03 | 2011-06-30 | Элан Фарма Интернэшнл Лтд. | Препараты наночастиц мезилата иматиниба |
WO2006133045A1 (en) * | 2005-06-03 | 2006-12-14 | Elan Pharma International, Limited | Nanoparticulate benidipine compositions |
US20060292214A1 (en) * | 2005-06-03 | 2006-12-28 | Elan Pharma International Limited | Nanoparticulate acetaminophen formulations |
JP2009517485A (ja) | 2005-06-08 | 2009-04-30 | エラン・ファルマ・インターナショナル・リミテッド | セフジトレンを含むナノ粒子状および制御放出組成物 |
DE602006010070D1 (de) * | 2005-06-09 | 2009-12-10 | Elan Pharma Int Ltd | Nanopartikuläre ebastinformulierungen |
EA200800041A1 (ru) * | 2005-06-13 | 2008-04-28 | Элан Фарма Интернэшнл Лтд. | Составы с наночастицами клопидогреля, содержащие комбинацию клопидогреля и аспирина |
US20100221327A1 (en) * | 2005-06-15 | 2010-09-02 | Elan Pharma International Limited | Nanoparticulate azelnidipine formulations |
US20070015719A1 (en) * | 2005-07-07 | 2007-01-18 | Elan Pharma International Limited | Nanoparticulate clarithromycin formulations |
CA2617909C (en) * | 2005-08-05 | 2014-02-04 | 3M Innovative Properties Company | Compositions exhibiting improved flowability |
JP2009507925A (ja) * | 2005-09-13 | 2009-02-26 | エラン ファーマ インターナショナル リミテッド | ナノ粒子タダラフィル製剤 |
EP2279727A3 (de) | 2005-09-15 | 2011-10-05 | Elan Pharma International Limited | Nanoteilchenförmige Aripiprazolformulierungen |
WO2007038675A2 (en) * | 2005-09-28 | 2007-04-05 | Oxford Pharmaceutical Services Inc. | Pharmaceutical compositions for treating or preventing migraines |
JP2009514884A (ja) * | 2005-11-04 | 2009-04-09 | イーストマン ケミカル カンパニー | 難溶性医薬活性剤の投与のためのカルボキシアルキルセルロースエステル |
US20070104763A1 (en) * | 2005-11-10 | 2007-05-10 | Navinta Llc | Composition of fentanyl citrate oral solid transmucosal dosage form, excipient and binding material therefore, and methods of making |
US10042980B2 (en) | 2005-11-17 | 2018-08-07 | Gearbox Llc | Providing assistance related to health |
US20070112592A1 (en) * | 2005-11-17 | 2007-05-17 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Payments in providing assistance related to health |
US8532938B2 (en) | 2005-11-17 | 2013-09-10 | The Invention Science Fund I, Llc | Testing-dependent administration of a nutraceutical |
MX336930B (es) * | 2005-11-28 | 2016-02-05 | Marinus Pharmaceuticals | Formulaciones de ganaxolona y metodos para la manufactura y el uso de las mismas. |
US20070299693A1 (en) * | 2006-06-23 | 2007-12-27 | Searete Llc, A Limited Liability Corporation | Customized visual marking for medication labeling |
US20080082272A1 (en) * | 2005-11-30 | 2008-04-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational systems and methods related to nutraceuticals |
US10296720B2 (en) | 2005-11-30 | 2019-05-21 | Gearbox Llc | Computational systems and methods related to nutraceuticals |
US9572886B2 (en) | 2005-12-22 | 2017-02-21 | Nitto Denko Corporation | Agent for treating myelofibrosis |
US8367112B2 (en) * | 2006-02-28 | 2013-02-05 | Alkermes Pharma Ireland Limited | Nanoparticulate carverdilol formulations |
ES2609388T3 (es) * | 2006-03-22 | 2017-04-20 | Syncore Biotechnology Co., Ltd | Tratamiento del cáncer de mama triple negativo a receptores |
US20070264350A1 (en) * | 2006-05-15 | 2007-11-15 | Ebara Corporation | Water-insoluble medicine |
MX2008015275A (es) * | 2006-05-30 | 2009-02-06 | Elan Pharma Int Ltd | Formulaciones de posaconazol en nanoparticulas. |
US20070281031A1 (en) * | 2006-06-01 | 2007-12-06 | Guohan Yang | Microparticles and methods for production thereof |
JP2009541360A (ja) * | 2006-06-23 | 2009-11-26 | エラン・ファルマ・インターナショナル・リミテッド | ナノ粒子状メロキシカムおよび制御放出ヒドロコドンを含む組成物 |
US20080086338A1 (en) * | 2006-06-23 | 2008-04-10 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Customized visual marking for medication labeling |
US20080086339A1 (en) * | 2006-06-23 | 2008-04-10 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Customized visual marking for medication labeling |
US20070299695A1 (en) * | 2006-06-23 | 2007-12-27 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Customized visual marking for medication labeling |
WO2008000042A1 (en) | 2006-06-30 | 2008-01-03 | Iceutica Pty Ltd | Methods for the preparation of biologically active compounds in nanoparticulate form |
CN104288103B (zh) * | 2006-06-30 | 2019-10-15 | 伊休蒂卡有限公司 | 用于制备纳米粒形式的生物活性化合物的方法 |
JP2009543797A (ja) * | 2006-07-10 | 2009-12-10 | エラン ファーマ インターナショナル,リミティド | ナノ粒子ソラフェニブ製剤 |
KR20090031618A (ko) * | 2006-07-12 | 2009-03-26 | 엘란 코포레이션, 피엘씨 | 나노입자형 모다피닐 제제 |
PT2049123E (pt) | 2006-08-03 | 2013-03-06 | Horizon Pharma Ag | Tratamento de doença reumatóide com glucocorticóide de libertação retardada |
EP2056883B1 (de) | 2006-08-04 | 2021-09-22 | Baxter International Inc. | Zusammensetzung auf mikrokügelchenbasis zur vorbeugung und/oder abwendung einer neuerkrankung an autoimmunem diabetes |
AU2007319577A1 (en) * | 2006-10-06 | 2008-05-22 | Baxter Healthcare S.A. | Microencapsules containing surface-modified microparticles and methods of forming and using the same |
US20080181966A1 (en) * | 2006-10-18 | 2008-07-31 | Cephalon, Inc. | Modafinil pharmaceutical compositions |
US20100239661A1 (en) * | 2006-10-26 | 2010-09-23 | Sunilendu Bhushan Roy | Pharmaceutical compositions of ursodiol |
JP2010510988A (ja) * | 2006-11-28 | 2010-04-08 | マリナス ファーマシューティカルズ | ナノ粒子製剤とその製造方法およびその利用 |
US9456983B1 (en) * | 2006-12-08 | 2016-10-04 | Advanced Cardiovascular Systems, Inc. | Therapeutic composition with enhanced vessel targeting |
JP5415769B2 (ja) | 2006-12-26 | 2014-02-12 | 株式会社新日本科学 | 経鼻投与用製剤 |
EP2120945A1 (de) * | 2007-02-28 | 2009-11-25 | Collegium Pharmaceutical, Inc. | Antihistamin-kombination |
DE602008002073D1 (de) * | 2007-03-02 | 2010-09-16 | Farnam Co Inc | Wachsähnliches material enthaltende tabletten mit verzögerter freisetzung |
TWI407971B (zh) | 2007-03-30 | 2013-09-11 | Nitto Denko Corp | Cancer cells and tumor-related fibroblasts |
US8530463B2 (en) * | 2007-05-07 | 2013-09-10 | Hale Biopharma Ventures Llc | Multimodal particulate formulations |
JP2010526822A (ja) * | 2007-05-07 | 2010-08-05 | クエスター ファーマシューティカルズ,インク. | ベンゾジアゼピン類の経鼻投与 |
TW200904340A (en) | 2007-05-11 | 2009-02-01 | Mannatech Inc | Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same |
CA2698812A1 (en) | 2007-09-14 | 2009-03-19 | Nitto Denko Corporation | Drug carriers |
WO2009108407A1 (en) * | 2008-02-25 | 2009-09-03 | The University Of North Carolina At Charlotte Office Of Technology Transfer | Biodegradable therapeutic nanoparticles containing an antimicrobial agent |
DK2548456T3 (en) | 2008-03-20 | 2015-09-28 | Virun Inc | Emulsions including (comprising) a PEG derivative of tocopherol |
JP2011520779A (ja) * | 2008-03-21 | 2011-07-21 | エラン・ファルマ・インターナショナル・リミテッド | イマチニブの部位特異的送達のための組成物および使用の方法 |
US20090258865A1 (en) * | 2008-03-28 | 2009-10-15 | Hale Biopharma Ventures, Llc | Administration of benzodiazepine compositions |
US8337931B2 (en) * | 2008-06-23 | 2012-12-25 | Virun, Inc. | Compositions containing non-polar compounds |
US8323685B2 (en) * | 2008-08-20 | 2012-12-04 | Baxter International Inc. | Methods of processing compositions containing microparticles |
US20100047292A1 (en) * | 2008-08-20 | 2010-02-25 | Baxter International Inc. | Methods of processing microparticles and compositions produced thereby |
US8367427B2 (en) * | 2008-08-20 | 2013-02-05 | Baxter International Inc. | Methods of processing compositions containing microparticles |
US8323615B2 (en) * | 2008-08-20 | 2012-12-04 | Baxter International Inc. | Methods of processing multi-phasic dispersions |
TWI494108B (zh) * | 2009-01-26 | 2015-08-01 | Nitec Pharma Ag | 糖皮質激素用以製備嚴重夜間氣喘用之於延遲釋放型的藥物之用途 |
NZ582836A (en) * | 2009-01-30 | 2011-06-30 | Nitec Pharma Ag | Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage |
WO2010102065A1 (en) | 2009-03-05 | 2010-09-10 | Bend Research, Inc. | Pharmaceutical compositions of dextran polymer derivatives |
CN103932988A (zh) | 2009-04-24 | 2014-07-23 | 伊休蒂卡有限公司 | 吲哚美辛的新剂型 |
NZ595987A (en) | 2009-04-24 | 2014-02-28 | Iceutica Pty Ltd | A novel formulation of diclofenac |
EP2429495A4 (de) * | 2009-05-15 | 2014-01-22 | Shin Nippon Biomedical Lab Ltd | Intranasale pharmazeutische zusammensetzung mit verbesserter pharmakokinetik |
JP6072539B2 (ja) | 2009-05-27 | 2017-02-01 | アルカーメス ファーマ アイルランド リミテッド | ナノ粒子活性物質組成物におけるフレーク状凝集の軽減 |
US20110021825A1 (en) * | 2009-07-21 | 2011-01-27 | Ge Healthcare As | Process for isolating iodixanol from an aqueous solution |
US8827946B2 (en) | 2009-07-31 | 2014-09-09 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator |
EP2563164B1 (de) | 2010-03-23 | 2016-06-29 | Virun, Inc. | Nanoemulsionen enthaltend saccharosefettsäureester |
WO2011146583A2 (en) | 2010-05-19 | 2011-11-24 | Elan Pharma International Limited | Nanoparticulate cinacalcet formulations |
FR2960775A1 (fr) * | 2010-06-07 | 2011-12-09 | Ethypharm Sa | Microgranules resistants au detournement |
WO2011162802A1 (en) | 2010-06-21 | 2011-12-29 | Virun, Inc. | Compositions containing non-polar compounds |
JP6042330B2 (ja) | 2010-07-09 | 2016-12-14 | ビーエイチヴィ ファーマ、インコーポレイテッド | レモグリフロジンを含めた半減期が短い医薬品のための組合せ即時/遅延放出送達システム |
EP2468258A1 (de) * | 2010-12-22 | 2012-06-27 | LEK Pharmaceuticals d.d. | Verfahren zur Herstellung einer pharmazeutischen Zusammensetzung, die einen wenig löslichen, pharmazeutisch wirksamen Bestandteil umfasst |
US9060938B2 (en) | 2011-05-10 | 2015-06-23 | Bend Research, Inc. | Pharmaceutical compositions of active agents and cationic dextran polymer derivatives |
ES2917973T3 (es) | 2011-06-14 | 2022-07-12 | Neurelis Inc | Administración de benzodiacepina |
BR112015009839A2 (pt) * | 2012-11-01 | 2017-07-11 | Torrent Pharmaceuticals Ltd | composição farmacêutica de tapentadol para administração parenteral |
AU2014232456B2 (en) | 2013-03-15 | 2018-11-15 | Glanbia Nutritionals (Ireland) Ltd. | Product and method for improving bioavailability of therapeutic compounds |
WO2015036792A1 (en) | 2013-09-16 | 2015-03-19 | Astrazeneca Ab | Therapeutic polymeric nanoparticles and methods of making and using same |
JP6251667B2 (ja) | 2014-06-03 | 2017-12-20 | アサヒカルピスウェルネス株式会社 | 錠剤型即放性製剤及びその製造方法 |
US9526734B2 (en) | 2014-06-09 | 2016-12-27 | Iceutica Pty Ltd. | Formulation of meloxicam |
US10016415B2 (en) | 2014-08-18 | 2018-07-10 | Alkermes Pharma Ireland Limited | Aripiprazole prodrug compositions |
SI3182958T2 (sl) * | 2014-08-18 | 2022-07-29 | Alkermes Pharma Ireland Limited | Sestavki aripiprazol predzdravila |
CA2967662A1 (en) | 2014-11-21 | 2016-05-26 | Biohaven Pharmaceutical Holding Company Ltd. | Sublingual formulation of riluzole |
CN108135838A (zh) | 2015-10-16 | 2018-06-08 | 马瑞纳斯制药公司 | 包含纳米粒的可注射神经类固醇制剂 |
WO2017105512A1 (en) * | 2015-12-18 | 2017-06-22 | Proinvet Innovations S.A. | Formulations and methods for controlling the reproductive cycle and ovulation |
IL292302B2 (en) | 2016-05-20 | 2023-10-01 | Biohaven Pharm Holding Co Ltd | Use of glutamate modulating factors in cancer immunotherapy |
EP3481387A4 (de) | 2016-08-11 | 2020-04-08 | Ovid Therapeutics Inc | Verfahren und zusammensetzungen zur behandlung von epileptischen erkrankungen |
US10391105B2 (en) | 2016-09-09 | 2019-08-27 | Marinus Pharmaceuticals Inc. | Methods of treating certain depressive disorders and delirium tremens |
EP4368169A2 (de) | 2016-12-31 | 2024-05-15 | Bioxcel Therapeutics, Inc. | Verwendung von sublingualem dexmedetomidin zur behandlung von unruhe |
US11744967B2 (en) | 2017-09-26 | 2023-09-05 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal delivery devices |
CN112292127A (zh) | 2017-11-12 | 2021-01-29 | 拜奥海芬治疗学有限公司 | 使用利鲁唑前药治疗共济失调 |
SG11202012772XA (en) | 2018-06-27 | 2021-01-28 | Bioxcel Therapeutics Inc | Film formulations containing dexmedetomidine and methods of producing them |
CN108904506A (zh) * | 2018-07-27 | 2018-11-30 | 河南大华生物技术有限公司 | 一种地克珠利纳米粉末及其制备方法 |
US11266662B2 (en) | 2018-12-07 | 2022-03-08 | Marinus Pharmaceuticals, Inc. | Ganaxolone for use in prophylaxis and treatment of postpartum depression |
KR20220049526A (ko) | 2019-07-19 | 2022-04-21 | 바이오엑셀 테라퓨틱스 인코포레이티드 | 비-진정성 덱스메데토미딘 치료 양생법 |
CN114728012A (zh) | 2019-08-05 | 2022-07-08 | 马瑞纳斯制药公司 | 用于治疗癫痫持续状态的加奈索酮 |
IL293525A (en) | 2019-12-06 | 2022-08-01 | Marinus Pharmaceuticals Inc | Ganaxolone for use in the treatment of multiple sclerosis complex |
US11806334B1 (en) | 2023-01-12 | 2023-11-07 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
Family Cites Families (111)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2403078A1 (fr) | 1977-09-19 | 1979-04-13 | Lafon Labor | Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic |
FR2561916B1 (fr) | 1984-03-30 | 1987-12-11 | Lafon Labor | Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau |
US4826689A (en) | 1984-05-21 | 1989-05-02 | University Of Rochester | Method for making uniformly sized particles from water-insoluble organic compounds |
US4783484A (en) | 1984-10-05 | 1988-11-08 | University Of Rochester | Particulate composition and use thereof as antimicrobial agent |
US4642903A (en) | 1985-03-26 | 1987-02-17 | R. P. Scherer Corporation | Freeze-dried foam dosage form |
FR2634376B1 (fr) * | 1988-07-21 | 1992-04-17 | Farmalyoc | Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation |
US5112616A (en) | 1988-11-30 | 1992-05-12 | Schering Corporation | Fast dissolving buccal tablet |
US5073374A (en) | 1988-11-30 | 1991-12-17 | Schering Corporation | Fast dissolving buccal tablet |
FR2685635B1 (fr) * | 1991-12-27 | 1995-06-30 | Lvmh Rech | Particules solides complexes comprenant une substance solide biologiquement active, leur mode de preparation et compositions a usage topique les renfermant destinees au traitement de surfaces biologiques. |
US5219574A (en) | 1989-09-15 | 1993-06-15 | Cima Labs. Inc. | Magnesium carbonate and oil tableting aid and flavoring additive |
US5178878A (en) | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
US5223264A (en) | 1989-10-02 | 1993-06-29 | Cima Labs, Inc. | Pediatric effervescent dosage form |
US5188825A (en) | 1989-12-28 | 1993-02-23 | Iles Martin C | Freeze-dried dosage forms and methods for preparing the same |
US5110605A (en) | 1990-08-21 | 1992-05-05 | Oramed, Inc. | Calcium polycarbophil-alginate controlled release composition and method |
US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
AU642066B2 (en) | 1991-01-25 | 1993-10-07 | Nanosystems L.L.C. | X-ray contrast compositions useful in medical imaging |
US5552160A (en) | 1991-01-25 | 1996-09-03 | Nanosystems L.L.C. | Surface modified NSAID nanoparticles |
US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
GB2257707B (en) * | 1991-05-27 | 1995-11-01 | Nippon Zeon Co | Adhesive composition |
WO1993000933A1 (en) | 1991-07-05 | 1993-01-21 | University Of Rochester | Ultrasmall non-aggregated porous particles entrapping gas-bubbles |
US5464632C1 (en) | 1991-07-22 | 2001-02-20 | Prographarm Lab | Rapidly disintegratable multiparticular tablet |
US5215758A (en) | 1991-09-11 | 1993-06-01 | Euroceltique, S.A. | Controlled release matrix suppository for pharmaceuticals |
US5610294A (en) | 1991-10-11 | 1997-03-11 | The Du Pont Merck Pharmaceutical Company | Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
DE4203932A1 (de) | 1992-02-11 | 1993-08-12 | Deutsche Aerospace | Sende-/empfangsmodul |
NZ248813A (en) | 1992-11-25 | 1995-06-27 | Eastman Kodak Co | Polymeric grinding media used in grinding pharmaceutical substances |
US5349957A (en) | 1992-12-02 | 1994-09-27 | Sterling Winthrop Inc. | Preparation and magnetic properties of very small magnetite-dextran particles |
US5346702A (en) | 1992-12-04 | 1994-09-13 | Sterling Winthrop Inc. | Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization |
US5298262A (en) | 1992-12-04 | 1994-03-29 | Sterling Winthrop Inc. | Use of ionic cloud point modifiers to prevent particle aggregation during sterilization |
US5302401A (en) | 1992-12-09 | 1994-04-12 | Sterling Winthrop Inc. | Method to reduce particle size growth during lyophilization |
US5340564A (en) | 1992-12-10 | 1994-08-23 | Sterling Winthrop Inc. | Formulations comprising olin 10-G to prevent particle aggregation and increase stability |
US5336507A (en) | 1992-12-11 | 1994-08-09 | Sterling Winthrop Inc. | Use of charged phospholipids to reduce nanoparticle aggregation |
US5429824A (en) | 1992-12-15 | 1995-07-04 | Eastman Kodak Company | Use of tyloxapole as a nanoparticle stabilizer and dispersant |
US5352459A (en) | 1992-12-16 | 1994-10-04 | Sterling Winthrop Inc. | Use of purified surface modifiers to prevent particle aggregation during sterilization |
US5401492A (en) | 1992-12-17 | 1995-03-28 | Sterling Winthrop, Inc. | Water insoluble non-magnetic manganese particles as magnetic resonance contract enhancement agents |
US5326552A (en) | 1992-12-17 | 1994-07-05 | Sterling Winthrop Inc. | Formulations for nanoparticulate x-ray blood pool contrast agents using high molecular weight nonionic surfactants |
US5503846A (en) | 1993-03-17 | 1996-04-02 | Cima Labs, Inc. | Base coated acid particles and effervescent formulation incorporating same |
US5264610A (en) | 1993-03-29 | 1993-11-23 | Sterling Winthrop Inc. | Iodinated aromatic propanedioates |
US5811404A (en) | 1993-05-14 | 1998-09-22 | Cytel Corporation | Sialyl Lex analogues as inhibitors of cellular adhesion |
US5631553A (en) * | 1993-05-31 | 1997-05-20 | Universite Du Quebec A Trois-Rivieres | High precision RF vector analysis system based on synchronous sampling |
AU691195B2 (en) | 1993-07-09 | 1998-05-14 | R.P. Scherer Corporation | Method for making freeze dried drug dosage forms |
US5622719A (en) | 1993-09-10 | 1997-04-22 | Fuisz Technologies Ltd. | Process and apparatus for making rapidly dissolving dosage units and product therefrom |
US5851553A (en) | 1993-09-10 | 1998-12-22 | Fuisz Technologies, Ltd. | Process and apparatus for making rapidly dissolving dosage units and product therefrom |
US5895664A (en) | 1993-09-10 | 1999-04-20 | Fuisz Technologies Ltd. | Process for forming quickly dispersing comestible unit and product therefrom |
US5595761A (en) | 1994-01-27 | 1997-01-21 | The Board Of Regents Of The University Of Oklahoma | Particulate support matrix for making a rapidly dissolving tablet |
US5576014A (en) | 1994-01-31 | 1996-11-19 | Yamanouchi Pharmaceutical Co., Ltd | Intrabuccally dissolving compressed moldings and production process thereof |
US5635210A (en) | 1994-02-03 | 1997-06-03 | The Board Of Regents Of The University Of Oklahoma | Method of making a rapidly dissolving tablet |
US5718388A (en) | 1994-05-25 | 1998-02-17 | Eastman Kodak | Continuous method of grinding pharmaceutical substances |
TW384224B (en) | 1994-05-25 | 2000-03-11 | Nano Sys Llc | Method of preparing submicron particles of a therapeutic or diagnostic agent |
US5567439A (en) | 1994-06-14 | 1996-10-22 | Fuisz Technologies Ltd. | Delivery of controlled-release systems(s) |
US5525328A (en) | 1994-06-24 | 1996-06-11 | Nanosystems L.L.C. | Nanoparticulate diagnostic diatrizoxy ester X-ray contrast agents for blood pool and lymphatic system imaging |
US5587143A (en) | 1994-06-28 | 1996-12-24 | Nanosystems L.L.C. | Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanoparticle compositions |
US5567172A (en) * | 1994-09-26 | 1996-10-22 | Aer Energy Resources, Inc. | Universal strain relief device for connectors |
GB9421836D0 (en) | 1994-10-28 | 1994-12-14 | Scherer Corp R P | Process for preparing solid pharmaceutical dosage forms of hydrophobic substances |
DE4440337A1 (de) * | 1994-11-11 | 1996-05-15 | Dds Drug Delivery Services Ges | Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit |
US5466440A (en) | 1994-12-30 | 1995-11-14 | Eastman Kodak Company | Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays |
US5628981A (en) | 1994-12-30 | 1997-05-13 | Nano Systems L.L.C. | Formulations of oral gastrointestinal diagnostic x-ray contrast agents and oral gastrointestinal therapeutic agents |
US5585108A (en) | 1994-12-30 | 1996-12-17 | Nanosystems L.L.C. | Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays |
US5662883A (en) | 1995-01-10 | 1997-09-02 | Nanosystems L.L.C. | Microprecipitation of micro-nanoparticulate pharmaceutical agents |
US5665331A (en) | 1995-01-10 | 1997-09-09 | Nanosystems L.L.C. | Co-microprecipitation of nanoparticulate pharmaceutical agents with crystal growth modifiers |
US5560932A (en) | 1995-01-10 | 1996-10-01 | Nano Systems L.L.C. | Microprecipitation of nanoparticulate pharmaceutical agents |
US5569448A (en) | 1995-01-24 | 1996-10-29 | Nano Systems L.L.C. | Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions |
US5639475A (en) | 1995-02-03 | 1997-06-17 | Eurand America, Incorporated | Effervescent microcapsules |
US5571536A (en) | 1995-02-06 | 1996-11-05 | Nano Systems L.L.C. | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
US5560931A (en) | 1995-02-14 | 1996-10-01 | Nawosystems L.L.C. | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
US5534270A (en) | 1995-02-09 | 1996-07-09 | Nanosystems Llc | Method of preparing stable drug nanoparticles |
US5593657A (en) | 1995-02-09 | 1997-01-14 | Nanosystems L.L.C. | Barium salt formulations stabilized by non-ionic and anionic stabilizers |
US5518738A (en) | 1995-02-09 | 1996-05-21 | Nanosystem L.L.C. | Nanoparticulate nsaid compositions |
US5622938A (en) | 1995-02-09 | 1997-04-22 | Nano Systems L.L.C. | Sugar base surfactant for nanocrystals |
US5500204A (en) | 1995-02-10 | 1996-03-19 | Eastman Kodak Company | Nanoparticulate diagnostic dimers as x-ray contrast agents for blood pool and lymphatic system imaging |
US5591456A (en) | 1995-02-10 | 1997-01-07 | Nanosystems L.L.C. | Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer |
US5573783A (en) | 1995-02-13 | 1996-11-12 | Nano Systems L.L.C. | Redispersible nanoparticulate film matrices with protective overcoats |
US5510118A (en) | 1995-02-14 | 1996-04-23 | Nanosystems Llc | Process for preparing therapeutic compositions containing nanoparticles |
US5543133A (en) | 1995-02-14 | 1996-08-06 | Nanosystems L.L.C. | Process of preparing x-ray contrast compositions containing nanoparticles |
US5580579A (en) | 1995-02-15 | 1996-12-03 | Nano Systems L.L.C. | Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers |
ATE274341T1 (de) * | 1995-02-24 | 2004-09-15 | Elan Pharma Int Ltd | Nanopartikel-dispersionen enthaltende aerosole |
US5718919A (en) | 1995-02-24 | 1998-02-17 | Nanosystems L.L.C. | Nanoparticles containing the R(-)enantiomer of ibuprofen |
US5747001A (en) | 1995-02-24 | 1998-05-05 | Nanosystems, L.L.C. | Aerosols containing beclomethazone nanoparticle dispersions |
US5565188A (en) | 1995-02-24 | 1996-10-15 | Nanosystems L.L.C. | Polyalkylene block copolymers as surface modifiers for nanoparticles |
US5472683A (en) | 1995-03-09 | 1995-12-05 | Eastman Kodak Company | Nanoparticulate diagnostic mixed carbamic anhydrides as X-ray contrast agents for blood pool and lymphatic system imaging |
US5643552A (en) | 1995-03-09 | 1997-07-01 | Nanosystems L.L.C. | Nanoparticulate diagnostic mixed carbonic anhydrides as x-ray contrast agents for blood pool and lymphatic system imaging |
US5573749A (en) | 1995-03-09 | 1996-11-12 | Nano Systems L.L.C. | Nanoparticulate diagnostic mixed carboxylic anhydrides as X-ray contrast agents for blood pool and lymphatic system imaging |
US5521218A (en) | 1995-05-15 | 1996-05-28 | Nanosystems L.L.C. | Nanoparticulate iodipamide derivatives for use as x-ray contrast agents |
US5573750A (en) | 1995-05-22 | 1996-11-12 | Nanosystems L.L.C. | Diagnostic imaging x-ray contrast agents |
US5607697A (en) | 1995-06-07 | 1997-03-04 | Cima Labs, Incorporated | Taste masking microparticles for oral dosage forms |
US5811388A (en) | 1995-06-07 | 1998-09-22 | Cibus Pharmaceutical, Inc. | Delivery of drugs to the lower GI tract |
US5834025A (en) | 1995-09-29 | 1998-11-10 | Nanosystems L.L.C. | Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions |
US5807578A (en) | 1995-11-22 | 1998-09-15 | Lab Pharmaceutical Research International Inc. | Fast-melt tablet and method of making same |
US5807577A (en) | 1995-11-22 | 1998-09-15 | Lab Pharmaceutical Research International Inc. | Fast-melt tablet and method of making same |
WO1998035666A1 (en) | 1997-02-13 | 1998-08-20 | Nanosystems Llc | Formulations of nanoparticle naproxen tablets |
US6045829A (en) * | 1997-02-13 | 2000-04-04 | Elan Pharma International Limited | Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers |
US5811425A (en) | 1997-03-04 | 1998-09-22 | Abbott Laboratories | Heterocyclic compounds as COX-2 inhibitors |
US5869098A (en) | 1997-08-20 | 1999-02-09 | Fuisz Technologies Ltd. | Fast-dissolving comestible units formed under high-speed/high-pressure conditions |
EP1021168A4 (de) * | 1997-10-09 | 2006-08-30 | Univ Vanderbilt | Mikro- und nanoapartikuläres, polymeres verabreichungssystem |
AU755993C (en) * | 1998-06-19 | 2003-10-30 | Skyepharma Canada Inc. | Processes to generate submicron particles of water-insoluble compounds |
US6153225A (en) | 1998-08-13 | 2000-11-28 | Elan Pharma International Limited | Injectable formulations of nanoparticulate naproxen |
EP1107782B1 (de) * | 1998-09-01 | 2009-12-23 | Merrion Research III Limited | Orale impfstoff-zusammensetzung |
US8293277B2 (en) * | 1998-10-01 | 2012-10-23 | Alkermes Pharma Ireland Limited | Controlled-release nanoparticulate compositions |
US6428814B1 (en) * | 1999-10-08 | 2002-08-06 | Elan Pharma International Ltd. | Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
US6375986B1 (en) * | 2000-09-21 | 2002-04-23 | Elan Pharma International Ltd. | Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate |
US6270806B1 (en) * | 1999-03-03 | 2001-08-07 | Elan Pharma International Limited | Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions |
US6267989B1 (en) * | 1999-03-08 | 2001-07-31 | Klan Pharma International Ltd. | Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions |
US6811813B1 (en) * | 1999-05-19 | 2004-11-02 | Sarnoff Corporation | Method of coating micrometer sized inorganic particles |
WO2001008299A1 (fr) * | 1999-07-23 | 2001-02-01 | Fujitsu Limited | Circuit miroir de courant basse tension |
US6649414B1 (en) * | 1999-08-17 | 2003-11-18 | Luminex Corporation | Microparticles with multiple fluorescent signals and methods of using same |
BR0008060A (pt) * | 1999-12-08 | 2002-02-05 | Pharmacia Corp | Composições inibidoras de ciclooxigenase-2 tendo rápido inìcio de eficácia terapêutica |
AU1756201A (en) * | 1999-12-08 | 2001-06-18 | Pharmacia Corporation | Nanoparticulate eplerenone compositions |
IL150353A0 (en) * | 1999-12-22 | 2002-12-01 | Pharmacia Corp | Dual-release compositions of a cyclooxygenase-2 inhibitor |
US6316029B1 (en) * | 2000-05-18 | 2001-11-13 | Flak Pharma International, Ltd. | Rapidly disintegrating solid oral dosage form |
US20040033267A1 (en) * | 2002-03-20 | 2004-02-19 | Elan Pharma International Ltd. | Nanoparticulate compositions of angiogenesis inhibitors |
US6589562B1 (en) * | 2000-10-25 | 2003-07-08 | Salvona L.L.C. | Multicomponent biodegradable bioadhesive controlled release system for oral care products |
US7112340B2 (en) * | 2001-10-19 | 2006-09-26 | Baxter International Inc. | Compositions of and method for preparing stable particles in a frozen aqueous matrix |
-
2002
- 2002-10-11 PT PT02800993T patent/PT1443912E/pt unknown
- 2002-10-11 US US10/268,928 patent/US6908626B2/en not_active Expired - Lifetime
- 2002-10-11 EP EP02800993A patent/EP1443912B1/de not_active Expired - Lifetime
- 2002-10-11 JP JP2003533905A patent/JP2005508939A/ja not_active Withdrawn
- 2002-10-11 AU AU2002334939A patent/AU2002334939A1/en not_active Abandoned
- 2002-10-11 WO PCT/US2002/032314 patent/WO2003030872A2/en active IP Right Grant
- 2002-10-11 AT AT02800993T patent/ATE371442T1/de active
- 2002-10-11 CA CA2463495A patent/CA2463495C/en not_active Expired - Lifetime
- 2002-10-11 DK DK02800993T patent/DK1443912T3/da active
- 2002-10-11 ES ES02800993T patent/ES2292848T3/es not_active Expired - Lifetime
- 2002-10-11 DE DE60222160T patent/DE60222160T2/de not_active Expired - Lifetime
-
2007
- 2007-11-22 CY CY20071101497T patent/CY1107810T1/el unknown
-
2009
- 2009-10-21 JP JP2009242799A patent/JP2010047599A/ja not_active Withdrawn
-
2013
- 2013-06-17 JP JP2013126534A patent/JP2013209422A/ja not_active Withdrawn
-
2015
- 2015-03-05 JP JP2015043408A patent/JP2015108022A/ja not_active Withdrawn
-
2017
- 2017-02-02 JP JP2017017261A patent/JP2017075182A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
PT1443912E (pt) | 2007-11-28 |
DE60222160T2 (de) | 2008-06-12 |
US6908626B2 (en) | 2005-06-21 |
ES2292848T3 (es) | 2008-03-16 |
JP2017075182A (ja) | 2017-04-20 |
EP1443912A2 (de) | 2004-08-11 |
CY1107810T1 (el) | 2013-06-19 |
JP2013209422A (ja) | 2013-10-10 |
AU2002334939A1 (en) | 2003-04-22 |
CA2463495C (en) | 2011-05-24 |
EP1443912B1 (de) | 2007-08-29 |
US20030137067A1 (en) | 2003-07-24 |
WO2003030872A3 (en) | 2003-07-31 |
ATE371442T1 (de) | 2007-09-15 |
JP2015108022A (ja) | 2015-06-11 |
WO2003030872A2 (en) | 2003-04-17 |
DK1443912T3 (da) | 2008-01-21 |
JP2005508939A (ja) | 2005-04-07 |
JP2010047599A (ja) | 2010-03-04 |
CA2463495A1 (en) | 2003-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60222160D1 (de) | Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung | |
ATE431131T1 (de) | Meloxican-formulierungen in nanoteilchenform | |
ATE343376T1 (de) | Nanopartikelzusammensetzungen von angiogeneseinhibitoren | |
DK1227529T3 (da) | Elektroluminescerende indretninger | |
ATE457718T1 (de) | Sterile gefilterte nanoteilchen-formulierungen von budesonid mit tyloxapol als oberflächenstabilisator | |
AU2003274680A1 (en) | Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent | |
ATE318295T1 (de) | Nanopartikuläre zubereitung | |
WO2000053164A9 (en) | Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions | |
DE60325718D1 (de) | Nystatin-nanopartikelzusammensetzungen | |
SG161203A1 (en) | Nanoparticulate tacrolimus formulations | |
WO2007053197A3 (en) | Nanoparticulate acetaminophen formulations | |
WO2001021154A3 (en) | Surface modified particulate compositions of biologically active substances | |
ATE481115T1 (de) | Hämostatische vorrichtungen und zusammensetzungen aus oxidierter zellulosepartikel und ein polysaccharid bindemittel | |
WO2003080024A3 (en) | Nanoparticulate compositions of map kinase inhibitors | |
WO2007075747A3 (en) | Uv-radiation protectant compositions | |
NZ573555A (en) | Nanoparticulate posaconazole formulations | |
ES2191616T3 (es) | Polvos pulverizables de fluoropolimeros no fibrilables. | |
IL158090A0 (en) | Colloidal suspension of nanoparticles based on an amphiphilic copolymer | |
CA2416109A1 (en) | Solid dose nanoparticulate compositions | |
WO2005009144A8 (de) | Pulverförmige phytosterol-formulierungen | |
DE50107695D1 (de) | Effektpigmente enthaltende pulverlacke und pulverlackdispersionen (pulverslurries) | |
ATE407674T1 (de) | Orale pharmazeutische formulierung in form einer wässrigen suspension von mikrokapseln zur modifizierten freisetzung von amoxicillin | |
ATE419834T1 (de) | Nanopartikel bestehend aus einem arzneistoff und copolymeren von vinyl pyrrolidon und vinyl acetat als oberflächenstabilisatoren | |
WO2007075381A3 (en) | Pharmaceutical compositions of ilaprazole | |
SG162811A1 (en) | Nanoparticulate and controlled release compositions comprising aryl- heterocyclic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: ELAN PHARMA INTERNATIONAL LTD., ATHLONE, WESTM, IE |
|
8364 | No opposition during term of opposition |